Jenny P. Y. Ting

Last updated
Jenny P. Y. Ting
Born
Taiwan
CitizenshipAmerican
Education
Scientific career
Institutions University of North Carolina

Jenny Pan-Yun Ting is a Chinese-American immunologist and microbiologist at University of North Carolina. She is a highly cited researcher who studies the role of NLR genes in regulating inflammation and how nanoparticles and microparticles can be used as vaccine adjuvants. She was president of the American Association of Immunologists from 2020 to 2021.

Contents

Early life and education

Jenny Pan-Yun Ting was born in Taiwan. She immigrated to the US after receiving a foreign student scholarship from Illinois State University. She graduated in 1975 with a bachelor's degree in medical technology. She then attended Northwestern University for her PhD before completing post-doctoral research appointments at University of Southern California and Duke University. [1]

Career

In 1984 Ting was hired as an assistant professor at the University of North Carolina. She was promoted to associate professor in 1990 and full professor in 1993. She received a named professorship in 2009, becoming the William Rand Kenan Professor. Since 1991 she has been leader of the immunology program at UNC Lineberger Comprehensive Cancer Center. She has been director of its Center for Translational Immunology and co-director of its Institute of Inflammatory Diseases since 2008. [2] Ting's research areas include the NLR gene family, which act as regulators of inflammation. She also researches vaccine adjuvants, including the possible use of nanoparticles and microparticles, for cancers that are difficult to treat like triple-negative breast cancer or for infectious diseases like dengue fever or zika fever. [3]

She has served on the editorial boards of several journals, including the Journal of Immunology , Molecular and Cellular Biology , [2] and the Annual Review of Immunology . [4]

Awards and honors

Ting was elected to the Henry Kunkel Society and the Academia Sinica in 2015. In 2015 and 2016 she was a Thomas Reuter Highly Cited Researcher; in 2018 and 2019 she was a Clarivate/Analytics Highly Cited Researcher. She was vice president of the American Association of Immunologists from 2019 to 2020 [3] and named the president for 2020 to 2021. She was the first woman of color to serve as the organization's president. [5]

In 2010, she was inducted into the Illinois State University College of Applied Science and Technology Hall of Fame. [1] She received the NCI Outstanding Investigator Award from 2016 to 2019. [3] In 2022, she was elected as a member of the National Academy of Sciences [6] and the American Academy of Arts and Sciences. [7]

Related Research Articles

Ellen S. Vitetta is the director of the Cancer Immunobiology Center at the University of Texas Southwestern Medical Center in Dallas.

<span class="mw-page-title-main">Yehuda Shoenfeld</span> Israeli physician

Yehuda Shoenfeld is an Israeli physician and autoimmunity researcher.

<span class="mw-page-title-main">Philippa Marrack</span> English biologist and immunologist based in the US

Philippa "Pippa" Marrack, FRS is an English immunologist and academic, based in the United States, best known for her research and discoveries pertaining to T cells. Marrack is the Ida and Cecil Green Professor and chair of the Department of Biomedical Research at National Jewish Health and a distinguished professor of immunology and microbiology at the University of Colorado Denver.

<span class="mw-page-title-main">Edison Liu</span>

Edison T. Liu is an American chemist who is the former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center (2012-2021). Before joining The Jackson Laboratory, he was the founding executive director of the Genome Institute of Singapore (GIS), chairman of the board of the Health Sciences Authority, and president of the Human Genome Organization (HUGO) (2007-2013). As the executive director of the GIS, he brought the institution to international prominence as one of the most productive genomics institutions in the world.

Hugh O'Neill McDevitt ForMemRS was an immunologist and Professor of Microbiology and Immunology at Stanford University School of Medicine.

<span class="mw-page-title-main">UNC Lineberger Comprehensive Cancer Center</span> Hospital in North Carolina, United States

The UNC Lineberger Comprehensive Cancer Center is a cancer research and treatment center at the University of North Carolina at Chapel Hill. One of 52 National Cancer Institute-designated comprehensive cancer centers in the United States, its clinical base is the N.C. Cancer Hospital, part of the UNC Health Care system. UNC Lineberger is the only public NCI-designated comprehensive cancer center in the state of North Carolina. The current director is H. Shelton Earp III who succeeded current NCI director Norman Sharpless.

<span class="mw-page-title-main">James P. Allison</span> American immunologist and Nobel laureate (born 1948)

James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19, and long COVID.

<span class="mw-page-title-main">Blossom Damania</span> American virologist

Blossom Damania is a virologist at the University of North Carolina at Chapel Hill. She is known for her work on oncogenic viruses that cause human cancer. Damania has also been serving as vice dean for research at the UNC Chapel Hill School of Medicine since 2016.

Kristy M. Ainslie is a Fred Eshelman Distinguished Professor in pharmaceutical science at University of North Carolina at Chapel Hill in the Eshelman School of Pharmacy and chair of the Division of Pharmacoengineering and Molecular Pharmaceutics. She is also joint in the UNC School of Medicine Department of Microbiology and Immunology and affiliated faculty in the UNC/NC State joint Biomedical Engineering department. Additionally, she is part of UNC's Biological and Biomedical Sciences Program (BBSP).

Irma Gigli is an emeritus professor at the University of Texas Health Science Center at Houston, and the Walter & Mary Mischer Distinguished Professor in Molecular Medicine, Hans J. Müller-Eberhard Chair in Immunology, and Director Emeritus of the IMM Center for Immunology & Autoimmune Diseases.

<span class="mw-page-title-main">Margaret Baird</span> New Zealand immunologist (1945–2016)

Margaret Alison Baird was a New Zealand immunologist. She was a full professor in the Department of Microbiology and Immunology at the University of Otago. Her research considered dendritic cells and their role in cancer and infectious disease.

Tania H. Watts is a Canadian Immunologist, Professor at the University of Toronto, past President of the Canadian Society for Immunology and from 2009-2019 held the Sanofi Pasteur Chair in Human Immunology at the University of Toronto. Tania Watts holds a Tier 1 Canada Research Chair in Anti-viral Immunity and was named a Distinguished Fellow of the American Association of Immunologists, class of 2022.

Stephanie S. Watowich is an American immunologist. Watowich is the deputy chair of the Department of Immunology at MD Anderson Cancer Center in Houston, TX. She is a professor within the department as well and serves as the co-director of the Center for Inflammation and Cancer at the MD Anderson Cancer Center. Watowich’s research has focused on transcriptional control of innate immunity, with specific interest in the actions of the cytokine-activated STAT transcriptional regulators.

<span class="mw-page-title-main">Kimryn Rathmell</span> American physician-scientist

W. Kimryn Rathmell is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the Director of the National Cancer Institute, and most recently served the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville, Tennessee. On November 17, 2023, Rathmell was nominated by President Biden as the next Director of the National Cancer Institute.

<span class="mw-page-title-main">Marc K. Jenkins</span> American Immunologist

Marc K. Jenkins is a Regents Professor and Director of the Center for Immunology at the University of Minnesota. He is a member of the National Academy of Sciences.

Mitzi Nagarkatti is a researcher and a university administrator who has served as the Chair of the Department of Pathology, Microbiology and Immunology at the University of South Carolina (USC) School of Medicine at Columbia, SC, since 2005. She is also the SmartState Endowed Chair of the Center for Cancer Drug Discovery and Carolina Distinguished Professor. She pursues research in inflammatory diseases, immunotoxicology, and immunopharmacology. She has been recognized for her research contributions through numerous awards leading to her election as a Fellow of the American Association for the Advancement of Science (AAAS), Fellow of the Academy of Toxicological Sciences, Fellow of the National Academy of Inventors, and Fellow of the American Academy of Microbiology. 

Roslyn A. Kemp is a New Zealand immunologist, and as of 2023 is a full professor at the University of Otago. Her research focuses on T cells, mucosal and tumour immune responses, inflammation and T cell memory.

Lieping Chen is a Chinese-American immunologist and physician-scientist.

References

  1. 1 2 "2010 CAST Hall of Fame Inductees". Illinois State University College of Applied Science and Technology.
  2. 1 2 "Jenny Pan-Yun Ting". Academia Sinica. Retrieved 11 February 2021.
  3. 1 2 3 "Jenny P. Ting". UNC Lineberger Comprehensive Cancer Center. Retrieved 10 February 2021.
  4. "Annual Review of Immunology, Current Editorial Committee". Annual Reviews. Retrieved 12 January 2021.
  5. "AAI President's Message". American Association of Immunologists. 2020. Retrieved 10 February 2021.
  6. "National Academy of Sciences elects Ting". The Well. 2022-05-04. Retrieved 2022-05-08.
  7. "Dr. Jenny Ting Elected to American Academy of Arts & Sciences". www.med.unc.edu. 2022-05-04. Retrieved 2022-05-08.